BMRN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Biomarin Pharmaceutical Inc's other long-term assets for the quarter that ended in Sep. 2014 was $661.7 Mil.
Biomarin Pharmaceutical Inc's quarterly other long-term assets increased from Mar. 2014 ($437.6 Mil) to Jun. 2014 ($438.3 Mil) and increased from Jun. 2014 ($438.3 Mil) to Sep. 2014 ($661.7 Mil).
Biomarin Pharmaceutical Inc's annual other long-term assets increased from Dec. 2011 ($333.1 Mil) to Dec. 2012 ($359.2 Mil) and increased from Dec. 2012 ($359.2 Mil) to Dec. 2013 ($575.1 Mil).
Assets are presented on the balance sheet in order of their liquidity. If a company expects to sell or otherwise recognize the economic value of an asset within one year, the asset is generally classified as a current asset on the balance sheet. Cash on hand is a common current asset.
A long-term asset is an asset that a company expects to sell or otherwise recognize the economic value of after more than one year. Property, plant and equipment, and intangible assets are common long-term assets. Except those two items and current assets, the others we treated as "Other Long Term Assets".
Biomarin Pharmaceutical Inc Annual Data
|Other Long-Term Assets||43.7||52.5||40.8||63.3||15.1||185.6||379.5||333.1||359.2||575.1|
Biomarin Pharmaceutical Inc Quarterly Data
|Other Long-Term Assets||363.8||175.2||359.2||366.4||375.2||401.3||575.1||437.6||438.3||661.7|